Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate-Reference-Cited by-同舟云学术

Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate

Published:2006-08-01 Issue:3 Volume:9 Page:254-260
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Anscher M S,Clough R,Robertson C N,Prosnitz L R,Dahm P,Walther P,Donatucci C F,Albala D M,Febbo P,George D J,Sun L,Moul J W

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/4500903.pdf

Reference37 articles.

1. Anscher MS, Prosnitz LR . Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 1987; 138: 1407–1412.

2. Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005; 366: 572–578.

3. Catton C, Gospodarowicz M, Warde P, Panzarella T, Catton P, McLean M et al. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol 2001; 59: 51–60.

4. Cheng WS, Frydenberg M, Bergstralh EJ, Larson-Keller JJ, Zincke H . Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome. Urology 1993; 42: 283–291.

5. Choo R, Hruby G, Hong J, Hong E, DeBoer G, Danjoux C et al. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not? Int J Radiat Oncol Biol Phys 2002; 52: 674–680.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA);BMC Cancer;2019-06-13

2. Prostate Cancer;Clinical Radiation Oncology;2016

3. Management of High-Risk/Locally Advanced Disease;Prostate Cancer: A Comprehensive Perspective;2012-12-10

4. Prostate Cancer;Clinical Radiation Oncology;2012

5. Post-radical prostatectomy management options for positive surgical margins: Argument for observation;Urologic Oncology: Seminars and Original Investigations;2009-01